Kuros Biosciences AG Income Statement

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	103.35	75.56	33.56	17.99	13.82	4.04
Revenue Growth (YoY)	129.81%	125.11%	86.61%	30.19%	242.04%	57.71%
Cost of Revenue	11.67	8.42	5.09	3.62	3.75	2.37
Gross Profit	91.68	67.13	28.47	14.37	10.07	1.67
Selling, General & Admin	80.14	60.16	31.78	19.38	14.05	9.66
Research & Development	7.68	6.98	2.03	5.19	4.99	4.01
Other Operating Expenses	0	-0.12	-0.25	-0.36	-0.21	-0.2
Operating Expenses	87.82	67.03	33.56	24.22	18.83	13.46
Operating Income	3.86	0.11	-5.09	-9.85	-8.77	-11.79
Interest Expense	-5.37	-0.15	-0.19	-	-1.38	-0.85
Interest & Investment Income	-	-	-	-	0.6	0.43
Currency Exchange Gain (Loss)	1.18	1.18	-2.3	-0.79	-	-
Other Non Operating Income (Expenses)	0.62	0.62	2.33	-1.75	-	-
EBT Excluding Unusual Items	0.28	1.76	-5.24	-12.39	-9.55	-12.2
Impairment of Goodwill	-5.1	-5.1	-4.37	-3.6	-	-
Asset Writedown	-	-	-0.17	-	-	-
Other Unusual Items	-	-	-	-	-	0.11
Pretax Income	-4.82	-3.35	-9.78	-15.99	-9.55	-12.09
Income Tax Expense	1.08	0.37	0.38	-1.4	-2.01	-0.57
Earnings From Continuing Operations	-5.9	-3.72	-10.16	-14.6	-7.54	-11.52
Earnings From Discontinued Operations	-0.17	-0.57	-3.57	-	-	-
Net Income	-6.07	-4.29	-13.73	-14.6	-7.54	-11.52
Net Income to Common	-6.07	-4.29	-13.73	-14.6	-7.54	-11.52
Shares Outstanding (Basic)	46	37	37	34	33	24
Shares Outstanding (Diluted)	46	37	37	34	33	24
Shares Change (YoY)	36.07%	1.69%	7.91%	3.37%	34.86%	53.69%
EPS (Basic)	-0.13	-0.12	-0.38	-0.43	-0.23	-0.47
EPS (Diluted)	-0.13	-0.12	-0.38	-0.43	-0.23	-0.47
Free Cash Flow	-0.67	2.05	-9.16	-7.74	-5.76	-9.3
Free Cash Flow Per Share	-0.01	0.06	-0.25	-0.23	-0.18	-0.38
Gross Margin	88.70%	88.85%	84.83%	79.89%	72.86%	41.37%
Operating Margin	3.73%	0.14%	-15.15%	-54.74%	-63.46%	-291.83%
Profit Margin	-5.87%	-5.68%	-40.90%	-81.15%	-54.59%	-285.22%
Free Cash Flow Margin	-0.65%	2.71%	-27.29%	-43.05%	-41.72%	-230.25%
EBITDA	5.82	2.06	-2.99	-7.5	-6.34	-9.48
EBITDA Margin	5.64%	2.72%	-8.91%	-41.70%	-45.90%	-234.81%
D&A For EBITDA	1.97	1.95	2.1	2.35	2.43	2.3
EBIT	3.86	0.11	-5.09	-9.85	-8.77	-11.79
EBIT Margin	3.73%	0.14%	-15.15%	-54.74%	-63.46%	-291.83%
Revenue as Reported	103.35	75.56	33.56	17.99	13.82	4.04

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.